ArticleIn vivo (Athens, Greece)

Safety and Efficacy of Imeglimin for Type 2 Diabetes in Patients Undergoing Dialysis.

Akira MimaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.